Although studies on AchE inhibitors and NMDA receptor antagonists are in depth, the effect of these drugs on patients with severe AD is still not optimistic even if bradycardia, syncope, and severe gastrointestinal adverse reactions, including esophageal rupture caused by drugs (especially AchE inhibitors), are ignored.133. This evidence concerns the gene ACHE and Alzheimer disease.